Morgan Stanley analyst Manan Gosalia raised the firm’s price target on Comerica (CMA) to $67 from $63 and keeps an Equal Weight rating on the shares. The “strong” Q3 beat was driven by net interest income, provision and expenses, the core 2025 NII story is “constructive,” and $100M of buybacks in Q4 are “starting sooner than expected,” the analyst tells investors in a post-earnings note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA:
- Comerica price target raised to $70 from $66 at Truist
- Comerica price target raised to $51 from $43 at Wells Fargo
- Comerica price target raised to $66 from $56 at Barclays
- Comerica says plans to repurchase $100M in common stock starting in Q4
- Morning Movers: CVS Health sinks following CEO change, weak guidance